Clinical Trials Directory

Trials / Completed

CompletedNCT02645903

Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy

Ultrasound-guided Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy: Randomized Controlled Double-blinded Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Inonu University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Living donor organ transplantation has increased in recent years due to an increased need for organs. The objective of this study was to investigate the effects of a TAP block on postoperative analgesia and opioid consumption in liver transplantation donors in whom a right lateral extending upper mid-line abdominal incision was used.

Detailed description

This prospective randomized controlled double-blinded study was conducted with 50 liver transplantation donors between 18-65 years who were scheduled to undergo right hepatectomy surgery. Cases to whom TAP block with ultrasound was applied after standard general anesthesia were determined as Group 1 and cases to whom only standard general anesthesia was applied, were determined as Group 2.

Conditions

Interventions

TypeNameDescription
DRUGTransversus Abdominis Plane BlockCases to whom used bupivacaine with ultrasound guided transversus abdominis plane block was applied after standard general anesthesia were determined as Group 1
DRUGstandard general anesthesiaCases to whom applied alone standard general anesthesia were determined as Group 2

Timeline

Start date
2015-05-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2016-01-05
Last updated
2016-01-06

Source: ClinicalTrials.gov record NCT02645903. Inclusion in this directory is not an endorsement.

Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy (NCT02645903) · Clinical Trials Directory